Copenhagen Sundhedshus Yavari ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
Estimate generation in progress, please wait...
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  0.5% 0.5% 0.5% 0.5% 0.5%  
Bankruptcy risk  8.1% 4.7% 2.1% 1.4% 0.9%  
Credit score (0-100)  31 45 65 78 86  
Credit rating  B BB BBB BBB A  
Credit limit (kDKK)  0.0 0.0 0.1 24.3 235.9  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  -82.4 -115 889 1,921 2,174  
EBITDA  -82.4 -506 177 872 839  
EBIT  -82.4 -506 165 859 825  
Pre-tax profit (PTP)  -85.3 814.4 163.9 851.7 813.8  
Net earnings  -85.3 651.5 111.0 663.6 631.3  
Pre-tax profit without non-rec. items  -85.3 814 164 852 814  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 55.1 41.6 28.1  
Shareholders equity total  -35.3 616 727 1,334 1,848  
Interest-bearing liabilities  938 0.0 0.3 7.4 8.2  
Balance sheet total (assets)  909 885 933 1,638 2,374  

Net Debt  29.1 -584 -425 -1,152 -1,503  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  -82.4 -115 889 1,921 2,174  
Gross profit growth  0.0% -39.5% 0.0% 116.0% 13.2%  
Employees  0 1 0 0 0  
Employee growth %  0.0% 0.0% -100.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  909 885 933 1,638 2,374  
Balance sheet change%  0.0% -2.7% 5.4% 75.5% 45.0%  
Added value  -82.4 -506.5 176.9 871.1 838.9  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 43 -27 -27  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -1.0 -2.0 1.0 2.0 3.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  100.0% 440.6% 18.5% 44.7% 38.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -8.7% 90.6% 18.7% 66.8% 41.1%  
ROI %  -8.8% 106.6% 25.3% 83.0% 51.6%  
ROE %  -9.4% 85.4% 16.5% 64.4% 39.7%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  -3.7% 69.6% 77.9% 81.4% 77.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -35.3% 115.3% -240.2% -132.1% -179.2%  
Gearing %  -2,657.5% 0.0% 0.0% 0.6% 0.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.6% 3.0% 4,881.5% 184.0% 148.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  1.0 2.4 3.2 4.5 4.0  
Current Ratio  1.0 2.4 3.2 4.5 4.0  
Cash and cash equivalent  909.4 583.7 425.2 1,159.5 1,511.2  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -35.3 385.2 442.1 1,053.8 1,580.9  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 -506 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 -506 0 0 0  
EBIT / employee  0 -506 0 0 0  
Net earnings / employee  0 652 0 0 0